Published in Novartis Found Symp on January 01, 1998
How stable is the risk curve between alcohol and all-cause mortality and what factors influence the shape? A precision-weighted hierarchical meta-analysis. Eur J Epidemiol (2003) 1.85
Exposure to cold and draught, alcohol consumption, and the NS-phenotype are associated with chronic bronchitis: an epidemiological investigation of 3387 men aged 53-75 years: the Copenhagen Male Study. Occup Environ Med (2001) 0.95
Generalized additive models applied to analysis of the relation between amount and type of alcohol and all-cause mortality. Eur J Epidemiol (2005) 0.79
Acetaldehyde burst protection of ADH1B*2 against alcoholism: an additional hormesis protection against esophageal cancers following alcohol consumption? Alcohol Clin Exp Res (2011) 0.76
Gender differences in alcohol consumption and adverse drinking consequences: cross-cultural patterns. Addiction (2000) 3.85
Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors. Proc Natl Acad Sci U S A (1994) 1.73
On the emerging paradigm of drinking patterns and their social and health consequences. Addiction (1996) 1.60
Identification of HIV vaccine candidate peptides by screening random phage epitope libraries. Virology (1993) 1.60
Moderate drinking and health. Implications of recent evidence. Can Fam Physician (1997) 1.50
Smoking in the home: changing attitudes and current practices. Am J Public Health (1998) 1.32
Detecting, preventing, and managing patients' alcohol problems. Can Fam Physician (1994) 1.29
Determinants of suggestions for alcohol treatment. Addiction (1996) 1.24
The effects of introducing or lowering legal per se blood alcohol limits for driving: an international review. Accid Anal Prev (2001) 1.21
The effects of light to moderate drinking on cardiovascular diseases. J Intern Med (1999) 1.09
A reliability and validity analysis of an alcohol-related harm scale for surveys. J Stud Alcohol (1999) 1.01
A systematic review and meta-analysis of the prevalence of chlamydia, gonorrhoea and syphilis in incarcerated persons. Int J STD AIDS (2012) 0.95
Immunogenicity of synthetic HIV-1 gp120 V3-loop peptide-conjugate immunogens. Vaccine (1994) 0.91
Guidelines on sensible drinking. Addiction (1996) 0.80
Safety and tolerance of trospium chloride in the high dose range. Arzneimittelforschung (1993) 0.79
Comments concerning the use of dimethylsulfoxide as a solvent for studies of chlordecone neurotoxicity. Neurotoxicology (1982) 0.76
Prevalence of screening in patients newly diagnosed with colorectal cancer in Ontario. Can J Gastroenterol (2007) 0.75
Triethyltin-induced neuronal damage in neonatally exposed rats. Neurotoxicology (1986) 0.75
Re: "Alcohol and mortality in Busselton, Western Australia". Am J Epidemiol (1994) 0.75
Pharmacokinetics and relative bioavailability of prajmalium bitartrate after single oral dosing. Arzneimittelforschung (1991) 0.75